What You Should Know:
– Aranscia, a global provider of diagnostics software, services, and testing solutions, has acquired select assets of the YouScript personalized medication management platform from Invitae Corporation in an all-cash transaction.
– YouScript…
Continue Reading
GE HealthCare’s AI can accurately predict patient responses to immunotherapy, as demonstrated in collaborative studies with VUMC and UME. The models, showcasing 70-80% accuracy, may guide more personalized treatment decisions, potentially minimizing side effects…
Continue Reading
A groundbreaking study reveals the effectiveness of liquid biopsy tests in guiding personalized treatment for non-small cell lung cancer (NSCLC) patients. Unlike conventional methods, these tests focus on circulating tumor DNA (ctDNA) levels, providing…
Continue Reading
Annmarie Ison, Head of Customer Service for the Oncology Software Solutions Business Line at Elekta The complex and dynamic landscape of multimodal cancer care is boosting demand for oncology-specific technological innovations. The need for…
Continue Reading
What You Should Know:
– Sheba Medical Center, Israel’s largest medical center, today announced the deployment of a new accelerated, AI-powered cancer diagnostics research platform that can shorten diagnostic time from three weeks to minutes.
–…
Continue Reading
Haystack Oncology was founded to dramatically improve patient outcomes with transformative precision oncology.What You Should Know:Quest Diagnostics has reached an agreement to acquire Haystack Oncology an early-stage oncology company focused on minimal residual disease (MRD) testing to aid…
Continue Reading
